Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Becton, Dickinson and Company clinical trials
Also known as BD.
The registry lists 194 studies whose lead sponsor is Becton, Dickinson and Company or one of 8 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Becton, Dickinson and Company studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Becton, Dickinson and Company.
- C. R. Bard117 studies →Acquired — became part of Becton, Dickinson and Company, Dec 29, 2017 · source ↗
Something wrong?
- Becton, Dickinson and Company61 studiesSame company
Something wrong?
- Straub Medical AG4 studies →Acquired — became part of Becton, Dickinson and Company, 2020 · source ↗
Something wrong?
- LifeBond Ltd.4 studies →Acquired
Something wrong?
- Medivance, Inc.2 studies →Acquired — became part of Becton, Dickinson and Company, Dec 29, 2017 · source ↗
Something wrong?
- SenoRx, Inc.2 studies →Acquired — became part of Becton, Dickinson and Company, Dec 29, 2017 · source ↗
Something wrong?
- Venclose, Inc.2 studies →Acquired — became part of Becton, Dickinson and Company, 2021 · source ↗
Something wrong?
- Velano Vascular, Inc.1 study →Acquired — became part of Becton, Dickinson and Company, Apr 2021 · source ↗
Something wrong?
- Clearstream Technologies Ltd.1 study →Acquired — became part of Becton, Dickinson and Company, Dec 29, 2017 · source ↗
Something wrong?
Focus areas
Conditions Becton, Dickinson and Company leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 194. Browse all 194 →
- Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICUEnrolling by invitationNCT07744945
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant AugmentationRecruitingNCT05945329Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- An Observational, Multinational, In Hospital Evaluation of Catheter Utilization Rates in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter Across Europe and the Middle EastNot yet recruitingNCT07798128
- HemoSphere Alta StudyRecruitingNCT07148323
- Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF SystemRecruitingNCT04634916Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- UK PureWick™ At-Home Pilot StudyRecruitingNCT07555548
- Personal BP - CAI StudyRecruitingNCT06492746Not applicable
- The Continuity StudyRecruitingNCT07216573Not applicable
- Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung ResectionNot yet recruitingNCT06934486
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal HypertensionRecruitingNCT06669806Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)RecruitingNCT07016698Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.CompletedNCT06850259Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Prophylactic Reinforcement of Ventral Abdominal Incisions TrialActive, not recruitingNCT03911700Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- The BD Liverty™ TIPS Stent Graft StudyActive, not recruitingNCT05711316Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult MalesCompletedNCT07282860Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- SMART TRENDS StudyCompletedNCT05957406Not applicable
- ClearSight NextGen1 StudyCompletedNCT07317648Not applicable
- Investigational Study With the BD PosiFlush™ SafeScrub on NADsCompletedNCT06604026Not applicable
- Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous FistulaeActive, not recruitingNCT03506308Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Venclose digiRF System Post Market StudyActive, not recruitingNCT05504070Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical StudyCompletedNCT06632496
- BD SiteRite(TM) 9 Ultrasound System - Clinical StudyCompletedNCT06632509
- Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal ArteriesCompletedNCT05556681Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.CompletedNCT05953363
- Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftCompletedNCT04261686Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- everlinQ endoAVF Post Market StudyTerminatedNCT02682420Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- everlinQ Endovascular Access Systems Enhancements (EASE-2) StudyCompletedNCT03708562Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural CatheterCompletedNCT02649894Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Test for Pre Operative Skin PreparationsCompletedNCT00799812Phase 3
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Topical Antimicrobial Effectiveness TestingCompletedNCT01366417Phase 4
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Topical Antimicrobial Effectiveness TestingCompletedNCT01314703Phase 4
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- everlinQ Endovascular Access System Enhancements (EASE) StudyCompletedNCT03708770Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Evaluating Safety and Effectiveness of Octenidine DihydrochlorideCompletedNCT03140254Phase 2
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Components of Chlorhexidine Gluconate DressingCompletedNCT01112020Phase 1
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Preoperative Skin Preparation EvaluationCompletedNCT00636480Phase 3
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 AntisepticsCompletedNCT00692484Phase 3
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural EffusionsCompletedNCT02227732Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)CompletedNCT02119832Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001CompletedNCT02119845Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Novel Endovascular Access Trial (NEAT)CompletedNCT02036671Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent ProductCompletedNCT06426121
- PureWick™ Adolescent StudyCompletedNCT06631313Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.CompletedNCT06666426Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- PureWick™ France and U.S. At-Home Pilot StudyCompletedNCT05710718Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay KitCompletedNCT04461678Not applicable
- Investigational On-body Injector Clinical StudyCompletedNCT05553418Not applicable
- A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free ConnectorsCompletedNCT05130762Not applicable
- The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market InvestigationTerminatedNCT04626427Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Post-Market Clinical Follow-up Study with ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVTCompletedNCT03116750
Sponsor listed in the registry: Straub Medical AG · First submitted before Straub Medical AG became part of Becton, Dickinson and Company
- BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.CompletedNCT05557422